journal
https://read.qxmd.com/read/37986652/fractionated-plasma-separation-and-adsorption-integrated-with-continuous-veno-venous-hemofiltration-in-patients-with-acute-liver-failure-a-single-center-experience-from-china
#21
JOURNAL ARTICLE
Jianhua Dong, Li Huang, Chuan Li, Bian Wu, Xi Yang, Yongchun Ge
OBJECTIVE: To evaluate the clinical efficacy and safety of fractionated plasma separation and adsorption integrated with continuous veno-venous hemofiltration (FPSA-CVVH) treatment in patients with acute liver failure (ALF). METHODS: In this retrospective study, we enrolled patients with ALF (serum total bilirubin >10 mg/dL or Model for End-Stage Liver Disease [MELD] Score >18) hospitalized between August 2017 and August 2022. All patients had at least two sessions of FPSA-CVVH...
November 20, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37941512/vascular-access-for-autologous-peripheral-blood-stem-cells-collection-by-large-volume-leukapheresis-single-center-experience
#22
JOURNAL ARTICLE
Ines Bojanić, Greta Novosel, Marijana Lukač Baričević, Petar Škrnjug, Elena Horvat, Sanja Mazić, Josip Batinić, Sandra Bašić Kinda, Branka Golubić Ćepulić
INTRODUCTION: Peripheral blood stem cell (PBSC) harvesting requires reliable and safe vascular access. In our institution, a change of practice was implemented and the central venous catheter (CVC) placement for all autologous PBSC collections was abandoned in favor of a careful evaluation of peripheral venous access (PVA) for each individual patient. The aim of this prospective study was to evaluate the rate of patients with adequate peripheral veins for autologous PBSC collection and compare patient characteristics, collection efficacy, and complication rate between patients with PVA and CVC...
November 8, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37937412/crude-collection-efficiency-of-cd34-hematopoietic-stem-cell-apheresis
#23
JOURNAL ARTICLE
Yandy Marx Castillo-Aleman
Understanding the apheresis principles for harvesting hematopoietic stem cells (HSCs) is critical for performing efficient procedures. However, despite significant advances in estimating the collection efficiency (CE) of aphereses, many confounding factors still need to be addressed in the classical calculations. The CE values are unrestricted, and many procedures exhibit CEs of a given cell population greater than 100%. This report introduces a simple equation that estimates the "crude" CE, which ranges from 0% to 100% and intrinsically considers the contribution of donor-related variables such as the pre-procedure mobilization and intra-apheresis recruitment of CD34+ cells (as a convenient marker for HSCs), as well as the performance of the apheresis system itself...
November 8, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37855194/comorbidity-in-lipoprotein-apheresis-their-role-in-the-era-of-new-lipid-lowering-therapies
#24
JOURNAL ARTICLE
Francesco Sbrana, Mascia Pianelli, Roberta Luciani, Federico Bigazzi, Carmen Corciulo, Andrea Ripoli, Tiziana Sampietro, Beatrice Dal Pino
BACKGROUND: Despite advance in pharmacotherapy of lipid disorders, lipoprotein apheresis (LA) plays a leading role in the management of severe hypercholesterolemia and in atherosclerosis prevention. METHODS: Aim of this study was to retrospectively evaluate Charlson Comorbidity Index (CCI), presence of major comorbidity, and/or concomitant polypharmacy (definite as 5+ drugs daily) in patients with inherited dyslipidemias on chronic LA. RESULTS: Since 1994, we performed more than 500 LA treatment/year and followed a total of 83 patients (age 56 [47-65] years, male 75%)...
October 19, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37850483/therapeutic-plasma-exchange-for-mechanical-red-cell-hemolysis-a-case-series
#25
Chloe E Douglas, Taylor R House, Larissa Yalon, Shina Menon
We present three cases of severely elevated plasma free hemoglobin (PFH) in pediatric patients on mechanical circulatory support devices at a tertiary pediatric care center. Due to severe levels of PFH in the setting of critical illness with the inability to pursue immediate mechanical device exchange, membrane filtration therapeutic plasma exchange (TPE) was performed, which resulted in a lowering of PFH levels. However, long-term outcomes were heterogeneous across the cases. This case series reviews patient presentation, organ function before and after TPE, and the overall role of TPE as an effective treatment option to decrease severely elevated PFH levels...
October 18, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37800533/hyperchloremic-metabolic-acidosis-after-plasma-exchange-in-a-patient-with-renal-transplant-rejection-a-case-report
#26
S S A Simon, M S van Sandwijk, R H G Olde Engberink
Therapeutic plasma exchange (TPE) is an effective treatment for several renal disorders, including renal transplant rejection. However, repeated plasma exchanges can result in various metabolic disturbances and complications. We present a 61-year old male with a medical history of type 2 diabetes, hypertension, successfully treated multiple myeloma, and a post-mortem kidney transplantation 7 months prior to presentation. The patient was hospitalized with an antibody-mediated transplant rejection for which treatment with methylprednisolone, TPE with a 40 g/L albumin solution as a replacement fluid, and intravenous immunoglobulins was initiated...
October 6, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37787399/adsorptive-cytapheresis-in-ulcerative-colitis-a-non-pharmacological-therapeutic-approach-revisited
#27
REVIEW
Filippo Vernia, Angelo Viscido, Giovanni Latella
Adsorptive cytapheresis proves effective in a proportion of patients affected by ulcerative colitis. Relatively high cost and the need for apheresis facilities, prevented the widespread use of this therapeutic approach. More so following the introduction of anti-TNFα biosimilars which proved both effective and inexpensive. Anti-TNFα agents, however, are burdened by high rate of primary and secondary non-response and prompt switching to new, high-cost biologics, and small molecules. The present review analyzes advantages and disadvantages of adsorptive cytapheresis in the present clinical scenario and suggests its repositioning in the therapeutic workup of selected subgroups of ulcerative colitis patients...
October 3, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37786990/effectiveness-of-leukapheresis-on-early-survival-in-acute-myeloid-leukemia-an-observational-propensity-score-matching-cohort-study
#28
JOURNAL ARTICLE
Howon Lee, Jay Ho Han, Jae Kwon Kim, Jaeeun Yoo, Hyung Suk Cho, Jae-Ho Yoon, Byung Sik Cho, Hee-Je Kim, Jihyang Lim, Dong Wook Jekarl, Yonggoo Kim
BACKGROUND: The association between leukapheresis (LK) as a treatment option for hyperleukocytosis (HL) in patients with acute myeloid leukemia (AML) remains controversial. METHODS: Data were extracted from the electronic medical record for 2801 patients with AML between April 2009 and December 2019. LK was performed when the leukocyte count was ≥100 × 109 /L at the time initial bone marrow examination. RESULTS: A comparison between the patients with HL in the non-LK (n = 1579) and LK (n = 208) groups revealed survival probabilities (%) of 93...
October 3, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37746743/updates-on-the-mobilization-pipeline-for-hematopoietic-stem-cell-collection
#29
REVIEW
Minh-Ha Tran, Muharrem Yunce
Hematopoetic Stem Cell Transplantation is a life saving procedure which requires mobilization of stem cells for apheresis procedure. In this review we aimed to examine mobilizing agents that are in use and under investigation. Apheresis practitioners who oversee stem cell collections should be familiar with the recent advances in mobilization agents to utilize most up-to-date information for better patient outcomes.
September 25, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37706521/therapeutic-plasma-exchange-decreases-plasma-anti-sars-cov-2-spike-igg-without-increasing-the-proximate-incidence-of-covid-19
#30
JOURNAL ARTICLE
Jensyn Cone Sullivan, Steven E Conklin, Stephanie Conrad, Coby Horowitz, Mark Diethelm, Raymond Comenzo
BACKGROUND: Therapeutic plasma exchange (TPE) removes both pathologic and protective immunoglobulins (Ig). SARS-CoV-2 immunity is partially mediated by anti-SARS-CoV-2 spike antibodies (SAb), which impair viral host-cell invasion. Nonetheless, the systematic effect of TPE on SAb concentration and SARS-CoV-2 immunity is unknown. METHODS: Paired plasma waste specimens from the first (first-TPE) and last (last-TPE) TPE treatment were collected from 9 patients between July 21, 2021 and March 1, 2022...
September 14, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37698143/immunity-in-the-balance-fatal-disseminated-adenovirus-infection-in-a-patient-undergoing-plasma-exchange-and-immunosuppressive-chemotherapy-for-anti-glomerular-basement-membrane-disease
#31
Jeremy W Jacobs, Cristina A Figueroa Villalba, Kristin Stendahl, Christopher A Tormey, Elizabeth Abels
Anti-glomerular basement membrane (anti-GBM) disease (formerly known as Goodpasture's syndrome) is a rare autoinflammatory condition that affects the renal and/or pulmonary capillaries. The standard therapeutic regimen for anti-GBM disease involves therapeutic plasma exchange (TPE), cyclophosphamide, and corticosteroids to rapidly remove and inhibit autoantibody production and reduce organ inflammation. Herein we report an 82-year-old female who developed anti-GBM disease but expired despite therapy, secondary to multi-organ failure in the setting of disseminated adenovirus disease...
September 12, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37665037/the-first-reported-use-of-red-blood-cell-exchange-to-treat-hemoglobin-evans-with-secondary-methemoglobinemia
#32
JOURNAL ARTICLE
Lance A Williams, Jill Adamski, Theresa N Kinard, Natalie M Ertz-Archambault, Qun Lu, Kristin Gray, Jennifer L Herrick, Leon Su, Leslie Padrnos
This manuscript describes a novel approach for treating patients with long-term sequelae from hemoglobin Evans (Hb Evans). After instituting conservative therapies for approximately 2 years, our patient's symptoms continually worsened. Therefore, we performed red blood cell exchange (RBCx) to reduce his Hb Evans percentage and his co-existing elevation of methemoglobin. Our assumptions of clinical benefit were based on our collective experience performing RBCx for patients with sickle cell disease. After the first exchange, pre- and post-laboratory results supported our approach and the patient experienced marked improvement in his clinical signs and symptoms...
September 4, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37605552/the-impact-of-the-covid-19-pandemic-on-source-plasma-donations
#33
JOURNAL ARTICLE
Mischa L Covington, Chesinta Voma, Sean R Stowell
While the COVID-19 pandemic has impacted many aspects of healthcare, including routine blood donations, the impact of COVID-19 on the donation of source plasma critical to many aspects of patient care, including apheresis procedures, has been more difficult to define. As production of plasma-derived medicinal products (PDMPs) can take up to a year, shortages in source plasma donations may not be immediately appreciated. Given current shortages in PDMPs, in particular albumin, we examined the impact of COVID-19 on source plasma donations...
August 22, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37574922/baseline-inflammation-indexes-and-neutrophil-to-ldh-ratio-for-prediction-of-the-first-mobilization-failure-without-plerixafor-based-regimens-in-multiple-myeloma-and-lymphoma-patients-a-single-center-retrospective-study
#34
JOURNAL ARTICLE
Ahmet Burak Dirim, Tarik Onur Tiryaki, Soner Altin, Sevgi Kalayoglu Besisik, Ipek Yonal Hindilerden, Meliha Nalcaci
BACKGROUND: Many factors were identified for mobilization failure (MF) in autologous hematopoietic stem-cell transplantation. To our knowledge, this is the first study to investigate the efficacy of baseline inflammation indexes and neutrophil-to-lactate dehydrogenase (LDH) ratio to predict MF in multiple myeloma (MM) and lymphoma. METHODS: A total of 240 patients with lymphoma or MM hospitalized between January 2014 and June 2022 for the first stem cell mobilization were included in this retrospective single-center study...
August 14, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37560907/navigating-the-neutropenic-abyss-with-granulocyte-transfusions-retrospective-single-center-analysis-of-effectiveness-and-safety-in-india
#35
JOURNAL ARTICLE
Priti Desai, Anisha Navkudkar, Bhausaheb Bagal, Chetan Dhamne, Hasmukh Jain, Manju Sengar, Girish Chinnaswamy, Lingaraj Nayak
BACKGROUND: Hemato-oncologic patients receiving intensive chemotherapy may develop severe neutropenia and serious bacterial and/or fungal infections. Granulocyte transfusions (GTs) may be beneficial as a bridging therapy in hemato-oncologic patients with febrile neutropenia. AIM: To evaluate the clinical effectiveness of GTs in hemato-oncologic patients with febrile neutropenia. MATERIALS AND METHODS: This retrospective study evaluated the effectiveness of 150 GTs in 88 hemato-oncologic patients...
August 10, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37559507/francis-s-morrison-md-tribute-to-an-apheresis-leader
#36
REVIEW
Walter Linz, James T Thigpen, Ronald G Strauss
Francis S. Morrison MD was among the early developers and promoters of the American Society for Apheresis (ASFA). His work was pivotal in creating a lasting institutional structure from which American apheresis medical practice would develop decades after his death. Francis Morrison is honored each year at the ASFA annual meeting as ASFA awards the Francis S. Morrison MD Memorial Award Lecture to an individual who stands out as among its most accomplished members. This tribute seeks to describe the person and the key accomplishments of Francis S...
August 10, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37548357/in-hospitalized-patients-undergoing-therapeutic-plasma-exchange-major-bleeding-prevalence-depends-on-the-bleeding-definition-an-analysis-of-the-recipient-epidemiology-and-donor-evaluation-study-iii
#37
JOURNAL ARTICLE
Alexandre Soares Ferreira Junior, Morgana Pinheiro Maux Lessa, Kate Sanborn, Maragatha Kuchibhatla, Matthew S Karafin, Oluwatoyosi A Onwuemene
BACKGROUND: Major bleeding in patients undergoing therapeutic plasma exchange (TPE) has been studied in large databases; but without standardizing bleeding definitions. Therefore, we used standardized definitions to evaluate major bleeding in hospitalized patients undergoing TPE using public use data files from the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). STUDY DESIGN AND METHODS: In a retrospective cross-sectional analysis, we identified TPE-treated adults in a first inpatient encounter...
August 7, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37526046/use-of-subgroup-specific-hematopoietic-stem-cell-collection-efficiencies-to-improve-truncation-calculations-for-large-volume-leukapheresis-procedures
#38
JOURNAL ARTICLE
Kai J Rogers, Sarah L Mott, Meredith G Parsons, Annette J Schlueter
PURPOSE: A critical component of optimizing peripheral blood (PB) hematopoietic stem cell (HSC) collections is accurately determining the processed blood volume required to collect the targeted number of HSCs. Fundamental to most truncation equations employed to determine this volume is the procedure's estimated collection efficiency (CE), which is typically applied uniformly across all HSC collections. Few studies have explored the utility of using different CEs in subpopulations of donors that have substantially different CEs than the institutional average...
August 1, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37525930/hemoglobin-s-target-of-50-as-compared-to-30-in-chronic-red-cell-exchange-for-secondary-stroke-prevention-in-sickle-cell-disease
#39
JOURNAL ARTICLE
Jihee Choi, John Emmanuel Markantonis, Nicole De Simone, Alecia Nero, Jaehyup Kim, Ravi Sarode
BACKGROUND: Sickle cell disease (SCD) patients with a history of stroke are encouraged to receive chronic red blood cell exchange (RBCx) for stroke prevention. The American Society of Hematology guideline published in 2020 recommends an HbS target of <30%. However, this approach necessitates more frequent RBCx and more RBC units. UT Southwestern has devised a chronic exchange protocol that elevates the HbS target to <50% in patients with a low risk of stroke. STUDY DESIGN: This retrospective chart review study reviewed the medical records of patients receiving chronic RBCx with a target of HbS <50% over the past 10-year period to assess the safety of maintaining higher HbS targets in SCD patients with a low risk of cerebrovascular accidents (CVA)...
August 1, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/36950971/investigation-on-the-feasibility-of-large-volume-autologous-red-blood-cells-donation-a-pilot-trial-in-a-small-cohort-of-chinese
#40
JOURNAL ARTICLE
Jinghui Wu, Guanyi Chen, Lihua Wang, Pan Wang, Yue Han, Lei Yang, Xilin Ouyang
BACKGROUND: Preoperative autologous blood donation (PAD) is used for elective surgical procedures with a predictable blood loss. But a downward trend in PAD is due to the fact that patients with preoperative whole blood donation or two-unit red cell apheresis cannot avoid receiving allogenic blood during intensive surgery. To improve the clinical application of PAD, this study explores the feasibility of large-volume autologous red blood cells (RBCs) donation by a pilot trial in a small cohort of Chinese...
August 2023: Journal of Clinical Apheresis
journal
journal
28458
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.